Endocrine Flashcards
Glucophage, Glucophage XR
metformin (PO)
Pharmacologic category: biguanide
Common indication: type 2 DM, PCOS
Key side effects: diarrhea, nausea, vomiting
US Boxed Warnings: lactic acidosis
Other Notes: CI if creatinine clearance < 30 mL/min
Onglyza
saxagliptin (PO)
Pharmacologic category: Dipeptidyl peptidase (DPP-4) inhibitor
Common indication: type 2 DM
Key side effects: headache, nasopharyngitis
Other Notes: heart failure requiring hospitalization and pancreatitis have occurred
Januvia
sitagliptin (PO)
Pharmacologic category: dipeptidyl peptidase (DPP-4) inhibitor
Common indication: type 2 DM
Key side effects: headache, nasopharyngitis
Other Notes: heart failure requiring hospitalization and pancreatitis have occurred
Victoza, Saxenda
liraglutide (subcutaneous)
Pharmacologic category: glucagon-like peptide-1 (GLP-1) receptor agonist
Common indication: type 2 DM, chronic weight management
Key side effects: nausea, vomiting, diarrhea, constipation
US Boxed Warnings: may increase risk of thyroid c-cell tumor
Humulin N, Novolin N
insulin NPH (subcutaneous)
Pharmacologic category: insulin, intermediate acting
Common indication: type 1 DM, type 2 DM
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Levemir
insulin detemir (subcutaneous)
Pharmacologic category: insulin, long acting
Common indication: type 1 DM, type 2 DM
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Lantus, Toujeo
insulin glargine (subcutaneous)
Pharmacologic category: insulin, long acting
Common indication: type 1 DM, type 2 DM
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Novolog
insulin aspart (subcutaneous)
Pharmacologic category: insulin, rapid acting
Common indication: type 1 DM, type 2 DM
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Humalog
insulin lispro (subcutaneous)
Pharmacologic category: insulin, rapid acting
Common indication: type 1 DM, type 2 DM
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Humulin R, Novolin R
insulin regular (subcutaneous, IV)
Pharmacologic category: insulin, short acting
Common indication: type 1 DM, type 2 DM, DKA
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Amaryl
glimepiride (PO)
Pharmacologic category: sulfonylurea
Common indication: type 2 DM
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Glucotrol, Glucotrol XL
glipizide (PO)
Pharmacologic category: sulfonylurea
Common indication: type 2 DM
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Glynase
glyburide (PO)
Pharmacologic category: sulfonylurea
Common indication: type 2 DM
Key side effects: hypoglycemia, weight gain
Other Notes: ISMP-high alert medication
Actos
pioglitazone (PO)
Pharmacologic category: thiazolinedione (TZD)
Common indication: type 2 DM
Key side effects: edema, weight gain, hypoglycemia, upper respiratory tract infection
US Boxed Warnings: may exacerbate congestive heart failure
Synthroid, Levoxyl
levothyroxine (PO, IV)
Pharmacologic category: thyroid product
Common indication: hypothyroidism
Key side effects: weight loss, palpitations, diarrhea, insomnia, heat intolerance
US Boxed Warnings: not intended for use for weight loss
Other Notes: narrow therapeutic index drug (toxicity may occur at concentrations close to therapeutic range; therapeutic monitoring is recommended); not all generic products are therapeutically equivalent